Rational design of iodinated silicon-fluorescein photosensitizers for optimal photodynamic efficacy.

Junshuai Ding, Yutong Shao, Han Sun, Ran An, Fengling Song

原始摘要（英文原文）· Original abstract

Herein, we investigate how iodine incorporation modulates the ROS kinetics of silicon-fluorescein derivatives, activating both Type I and II pathways that transcend empirical heavy-atom counting for optimal photodynamic therapy.

读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

Ultrasound-Triggered Type I Supramolecular Photosensitizer for Precise In Situ Chemiluminescence-Based Photodynamic Cyclic Therapy
Dinuclear Ru(II) complexes-based AIE agents with efficient type I/II ROS generation and photo-catalytic NADH oxidation trigger ferroptosis and immunogenic cell death for cancer therapy.
Deep-Red Multiple-Resonance B,N-Heteroarenes as Type I Photosensitizers for Fluorescence Imaging-Guided Photodynamic Therapy
Encapsulation of a Cyclometalated Iridium(III) Photosensitizer into Nanosized Micelles for Oncosis-Inducing Photodynamic Therapy
Advances in Nanotechnology‐Driven Enhancement of Type I Photosensitizers for Tumor Photo‐Immunotherapy